X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE ALEMBIC LTD TTK HEALTHCARE/
ALEMBIC LTD
 
P/E (TTM) x 19.1 53.4 35.8% View Chart
P/BV x 4.9 2.2 225.7% View Chart
Dividend Yield % 0.6 0.5 126.3%  

Financials

 TTK HEALTHCARE   ALEMBIC LTD
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
ALEMBIC LTD
Mar-18
TTK HEALTHCARE/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs66372 921.4%   
Low Rs39934 1,177.0%   
Sales per share (Unadj.) Rs535.64.7 11,394.8%  
Earnings per share (Unadj.) Rs15.96.1 261.3%  
Cash flow per share (Unadj.) Rs20.06.2 320.7%  
Dividends per share (Unadj.) Rs4.000.20 2,000.0%  
Dividend yield (eoy) %0.80.4 199.4%  
Book value per share (Unadj.) Rs137.640.7 338.5%  
Shares outstanding (eoy) m7.77267.03 2.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.011.3 8.8%   
Avg P/E ratio x33.38.7 384.0%  
P/CF ratio (eoy) x26.58.5 312.9%  
Price / Book Value ratio x3.91.3 296.4%  
Dividend payout %25.13.3 765.5%   
Avg Mkt Cap Rs m4,12714,139 29.2%   
No. of employees `0001.7NA-   
Total wages/salary Rs m607207 292.5%   
Avg. sales/employee Rs Th2,436.7NM-  
Avg. wages/employee Rs Th355.2NM-  
Avg. net profit/employee Rs Th72.5NM-  
INCOME DATA
Net Sales Rs m4,1621,255 331.6%  
Other income Rs m61370 16.5%   
Total revenues Rs m4,2231,625 259.8%   
Gross profit Rs m197111 177.4%  
Depreciation Rs m3238 83.9%   
Interest Rs m302 1,758.8%   
Profit before tax Rs m197442 44.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7324 304.0%   
Profit after tax Rs m1241,630 7.6%  
Gross profit margin %4.78.9 53.5%  
Effective tax rate %37.05.4 682.7%   
Net profit margin %3.0129.8 2.3%  
BALANCE SHEET DATA
Current assets Rs m1,6291,867 87.2%   
Current liabilities Rs m1,058591 178.9%   
Net working cap to sales %13.7101.6 13.5%  
Current ratio x1.53.2 48.8%  
Inventory Days Days3094 31.6%  
Debtors Days Days3474 45.7%  
Net fixed assets Rs m5561,791 31.1%   
Share capital Rs m78534 14.5%   
"Free" reserves Rs m87810,324 8.5%   
Net worth Rs m1,06910,858 9.8%   
Long term debt Rs m15941 385.2%   
Total assets Rs m2,39911,591 20.7%  
Interest coverage x7.6260.9 2.9%   
Debt to equity ratio x0.10 3,911.3%  
Sales to assets ratio x1.70.1 1,601.7%   
Return on assets %6.414.1 45.5%  
Return on equity %11.615.0 77.2%  
Return on capital %18.515.2 121.5%  
Exports to sales %0.81.5 51.1%   
Imports to sales %1.421.0 6.7%   
Exports (fob) Rs m3319 169.6%   
Imports (cif) Rs m58263 22.1%   
Fx inflow Rs m3319 169.6%   
Fx outflow Rs m63264 24.0%   
Net fx Rs m-30-244 12.4%   
CASH FLOW
From Operations Rs m127236 53.7%  
From Investments Rs m-146-224 65.2%  
From Financial Activity Rs m22-27 -82.3%  
Net Cashflow Rs m3-15 -16.9%  

Share Holding

Indian Promoters % 65.4 64.0 102.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 0.2 1,850.0%  
FIIs % 5.2 9.7 53.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 26.1 98.9%  
Shareholders   12,723 54,701 23.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   DR. DATSONS LABS  DISHMAN PHARMA  J.B.CHEMICALS  NATCO PHARMA  BIOCON   

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Get Ready for Record Highs(Podcast)

Globally, Traders were left scrambling after the Federal Reserve forecast zero interest-rate hikes this year and just one in 2020.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Mar 22, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS